Zhikang Zhao
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Alkaline phosphatase predicts short-term postoperative outcome in adult patients with moyamoya disease.
Journal: Frontiers in neurology
Published: May 07, 2025
Circulating T cell atlas in Moyamoya disease: insights into immunopathogenesis of cerebrovascular disorders.
Journal: Journal of neuroinflammation
Published: April 17, 2025
One-stage hybrid operation for hypervascular central nervous system tumors: a single-center experience of 31 cases.
Journal: Chinese neurosurgical journal
Published: February 10, 2025
Integrated bulk RNA sequencing and mass cytometry analysis reveal the circulating immune landscape in ischemic and hemorrhagic Moyamoya disease.
Journal: BMC immunology
Published: October 19, 2024
Taurine levels and long-term adverse cerebrovascular risk in moyamoya disease: A prognostic perspective study.
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: July 22, 2024
Mass cytometry revealed the circulating immune cell landscape across different Suzuki stages of Moyamoya disease.
Journal: Immunologic research
Published: December 21, 2023
Multiomics and blood-based biomarkers of moyamoya disease: protocol of Moyamoya Omics Atlas (MOYAOMICS).
Journal: Chinese neurosurgical journal
Published: October 20, 2023
T cells immune imbalance presents in patients with multiple intracranial aneurysms.
Journal: Clinical and experimental immunology
Published: October 18, 2023
Nonalcoholic fatty liver disease is an independent risk factor for ischemic stroke after revascularization in patients with Moyamoya disease: a prospective cohort study.
Journal: Lipids in health and disease
Published: October 16, 2023
Showing 1-11 of 11
Last Updated: 09/26/2026